NTRBW
Nutriband Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.51
Beta
1.96
52W High
$4.50
52W Low
$0.80
50-Day MA
$1.26
200-Day MA
$1.55
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Nutriband Inc. Warrant
Nutraband Inc. Warrant (NTRBW) represents a compelling investment proposition associated with Nutriband Inc., an innovative biotechnology firm that specializes in advanced transdermal drug delivery systems. The company is dedicated to enhancing patient care in pain management and addiction treatment through its cutting-edge therapeutic pipeline, addressing critical healthcare needs. With a strong emphasis on proprietary technologies and a forward-looking strategic approach, Nutriband is well-positioned to capitalize on emerging growth opportunities within the evolving pharmaceutical sector, making it an appealing option for institutional investors focused on biotech advancements.
Fundamentals
| Revenue (TTM) | $2.04M |
| Gross Profit (TTM) | 566,310 |
| EBITDA | $-8.12M |
| Operating Margin | -254.80% |
| Return on Equity | -125.60% |
| Return on Assets | -69.20% |
| Revenue/Share (TTM) | $0.17 |
| Book Value | $0.62 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -37.60% |
| Shares Outstanding | 0 |
| Float | $5.28M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
176.49%
HV 20-Day
155.99%
HV 30-Day
127.01%
HV 60-Day
118.51%
HV Rank
—
Volatility is currently expanding
Data last updated: 5/25/2026